Leaderboard

En | De
Sie sind hier: Onkologie » Haut 07. März 2026
Suchen
medline.ch
Haut
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7084  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 141678  
   
Obesity and melanoma: unraveling the paradoxical survival benefit in immunotherapy.
Cancer Metastasis Rev
Yang J, Hu Q, Xue C.
PMID: 41792481 [PubMed - in process]


Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies.
Curr Oncol Rep
Allen-Tejerina AM, Giannakis P, Ho Lai Yau T, Hillyar CRT, Rallis KS.
PMID: 41790359 [PubMed - in process]


SURGICAL HEMORRHOIDECTOMY UNEXPECTEDLY RESULTING IN DIAGNOSIS OF MUCOSAL MELANOMA.
Am J Gastroenterol
Zabala ZE, Sarkar Das T, Garzon W, Wakil A, Nayudu C Jr, Vigoda I, Venugopa S.
PMID: 41789817 [PubMed - as supplied by publisher]


Ultra-High-Frequency Ultrasound of Melanoma Excision Scars for Detection of Clinically Occult Local Recurrence: A Single-Center Retrospective Study.
Clin Cosmet Investig Dermatol
Russo A, Patanè V, Bucciero L, Brunese M, Troiani T, Argenziano G, Franco R, Reginelli A.
PMID: 41789056 [PubMed]


Melanoma of unknown primary presenting as intestinal obstruction: a diagnostic challenge.
Rom J Morphol Embryol
Palc, Andronic O, Bolocan A, Dinulescu A, P, Ion D, P.
PMID: 41787628 [PubMed - in process]


Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
J Immunother Cancer
Gaughan EM, Kim M, Mendez I, Rao AD, Wei M, So A, Zhong X, Berking C, Jiang R, Kim TM, Dalle S, Robert C, Danson S, Alam S, Charles J, Davies T, Debus D, Dzienis M, Frazer R, Gebhardt C, Geidel G, Hassel JC, Hansen I, Heppt MV, Hildebrandt L, Isaacs JM, Suh KJ, Keam B, Kim YJ, Lesimple T, Saiag P, Delibes A, Barnett R, Krepler C, Gandhi K, Qizilbash N, Shui IM, Tan XL, Sullivan RJ.
PMID: 41786455 [PubMed - in process]


Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.
Lancet Oncol
van den Hoek L, Burgmans M, Tong T, Goeman J, Speetjens F, Zunder S, van Erkel A, van der Meer R, van Rijswijk C, Lutjeboer J, Koolhaas D, Jonker-Bos M, Roozen I, Kropff S, van Meerten EVP, Zoethout R, Sitsen E, Helmerhorst H, Tijl F, Blank C, Kapiteijn E.
PMID: 41785896 [PubMed - indexed for MEDLINE]


Pleural Metastases From Acral Lentiginous Melanoma Diagnosed by Medical Thoracoscopy.
Respirol Case Rep
Chong AR, Ng KL, Huan NC, Mohd Aminudin NH, Hassan F, Mohamed Nordin K.
PMID: 41783719 [PubMed]


Metastatic Tumors from Unknown Primary in Cervical Lymph Nodes: A Decade of Study in a Tertiary Care Center of a Resource-Limited Country.
JNMA J Nepal Med Assoc
Kafle S.
PMID: 41783533 [PubMed - indexed for MEDLINE]


Efficacy and Safety of DNV3 (a Lymphocyte-activation Gene 3-blocking Antibody) Combined With Toripalimab and Chemotherapy in Advanced Melanoma: An Open-label, Single-arm Clinical Trial.
MedComm (2020)
Lin J, Chen L, Chen L, Wang D, Lu Y, Zhang H, Chen P, Yan W, Xiao Z, Chen Y.
PMID: 41782961 [PubMed]


Case Report: A case of superficial spreading malignant melanoma with sentinel lymph node metastasis misdiagnosed as "pigmented nevus".
Front Immunol
Bu X, Guo J, Feng L, Liu Y.
PMID: 41782886 [PubMed - indexed for MEDLINE]


Radiotherapy-Chemotherapy Combinations in Locally Advanced Head and Neck Squamous Cell Carcinoma.
J Coll Physicians Surg Pak
Chen YQ, Wu HJ.
PMID: 41781832 [PubMed - indexed for MEDLINE]


Cutaneous Epithelioid/Pleomorphic Rhabdomyosarcoma, Melanoma in Disguise? An Immunohistochemical, Molecular and Epigenetic Study of 13 Patients.
Mod Pathol
Ulici V, Ameline B, John I, Dermawan JK, Karunamurthy A, Dehner CA, Fernandez AP, Azzato E, Hattery T, Kilpatrick SE, Isaacson AL, Ko JS, Fritchie KJ, Baumhoer D, Billings SD.
PMID: 41780801 [PubMed - as supplied by publisher]


Integrated analysis identifies CCNA2 as a candidate diagnostic and prognostic biomarker in oral tongue squamous cell carcinoma.
J Appl Oral Sci
Gumedag C, Atay S.
PMID: 41779475 [PubMed - indexed for MEDLINE]


Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers in oral squamous cell carcinoma. An observational case-control study.
J Appl Oral Sci
Cruz-Romero SD, Baldión AM, Tawil JAH, Escallon A, Rodriguez-Urrego PA, Baldión PA.
PMID: 41779471 [PubMed - indexed for MEDLINE]


Comparison of [18F]PFPN and [18F]FDG PET in mucosal melanoma: diagnostic performance, staging impact, and correlation with molecular markers.
Clin Cancer Res
Lin Z, Tang C, Liu T, Wang X, Wu Z, Hu F, Gai Y, Ruan W, Zhang X, Lan X.
PMID: 41779012 [PubMed - as supplied by publisher]


AI-derived prognostic biomarkers from melanoma whole slide image segmentation: an initial discovery and assessment.
J Pathol Clin Res
Clarke EL, Magee D, Newton-Bishop J, Saldanha G, Merchant W, Hall M, Insall R, Maher NG, Scolyer RA, Farnworth G, Ali A, Bamford M, Sticova E, Kujal P, O'Shea S, Treanor D.
PMID: 41778962 [PubMed - indexed for MEDLINE]


An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective Study.
J Extracell Vesicles
Wang Y, Xing S, Wu YX, Xue N, Chen PM, Jin RX, Xu YW, Ji MF, Peng YH, Liu YT, Chen LN, Wu M, Jiang ZY, Xie SH, Luo YL, Zhang B, Ou XY, Huang Q, Tian BY, Ling L, Cao SM, Liu WL, Zeng MS, Zhong Q.
PMID: 41777088 [PubMed - indexed for MEDLINE]


Eight-year survival with metastatic oesophageal carcinoma: a case report and review of the literature.
S Afr J Surg
Kasai H, Begg W, Mihalik M.
PMID: 41776788 [PubMed - indexed for MEDLINE]


Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).
J Immunother Cancer
Ninmer EK, Petroni GR, Gastman BR, Gaughan EM, Isaacs JM, Haden K, Kaur V, Wages NA, Chianese-Bullock KA, Smith KT, Wright P, Bryant J, Dunlap-Brown M, Engel JA, Bekiranov S, Mauldin IS, Truong TG, Bullock TNJ, Slingluff CL Jr.
PMID: 41775435 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 141678    Seite 1 von 7084  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1